Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Promoting Pluripotency: A specialized mammalian cell can be set back to the pluripotent state either by transfer of the somatic cell nucleus into an oocyte or by delivery of exogenous pluripotency-associated transcription factors. Hou et al. (p. 651 , published online 18 July) developed an approach to induce pluripotency in somatic cells using a cocktail of small molecules. The ability to generate such chemically induced pluripotent stem cells may provide an alternate route for therapeutic cloning and for drug development in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developing a chemical alternative to mimic OSK’s rejuvenating effects could lower costs and shorten timelines in regenerative medicine development [26, 28–31].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [31]
In the citing paper
“Recent studies have demonstrated the potential of small molecule stimulation in facilitating chemical reprogramming by inducing an intermediate plastic state [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“These small molecules effectively target key signaling pathways involved in cellular reprogramming, benefiting both human and mouse somatic cells [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Self-citationSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.02.020 · Cited by 898
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Cited by
Items 301–400 of 1,005
iPSCs: A Comparison between Animals and Plants
Sang, Y. L., Cheng, Z. J., & Zhang, X. S. (2018) · Trends in Plant Science · doi:10.1016/j.tplants.2018.05.008 · Cited by 45
Self-citationcAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential
Kim, J.-J., Kim, D., Lee, J. Y., Lee, B., Kang, I., Kook, M. G., Kong, D., Choi, S. W., Woo, H., Kim, D., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.019 · Cited by 45
Livestock pluripotency is finally captured in vitro
Navarro, M., Soto, D. A., Pinzón-Arteaga, C. A., Wu, J., & Ross, P. J. (2019) · Reproduction Fertility and Development · doi:10.1071/rd19272 · Cited by 45
Bioactive Molecules for Skin Repair and Regeneration: Progress and Perspectives
Chen, D., Hou, Q., Zhong, L., Zhao, Y., Li, M., & Fu, X. (2019) · Stem Cells International · doi:10.1155/2019/6789823 · Cited by 45
Self-citationEmerging role of G9a in cancer stemness and promises as a therapeutic target
Haebe, J. R., Bergin, C. J., Sandouka, T., & Benoit, Y. D. (2021) · Oncogenesis · doi:10.1038/s41389-021-00370-7 · Cited by 45
Retinal repair with induced pluripotent stem cells
Alshamekh, S. A., & Goldberg, J. L. (2013) · Translational research · doi:10.1016/j.trsl.2013.11.002 · Cited by 44
Collaborative rewiring of the pluripotency network by chromatin and signalling modulating pathways
Tran, K. A., Jackson, S. A., Olufs, Z. P. G., Zaidan, N. Z., Leng, N., Kendziorski, C. M., Roy, S., & Sridharan, R. (2015) · Nature Communications · doi:10.1038/ncomms7188 · Cited by 44
Unzu, C., Planet, E., Brandenberg, N., Fusil, F., Cassano, M., Perez‐Vargas, J., Friedli, M., Cosset, F., Lutolf, M. P., Wildhaber, B. E., et al. (2019) · Hepatology · doi:10.1002/hep.30425 · Cited by 41
Iyer, A. A., & Groves, A. K. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.660748 · Cited by 44
Counteracting aged DNA methylation states to combat ageing and age-related diseases
Reale, A., Tagliatesta, S., Zardo, G., & Zampieri, M. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111695 · Cited by 44
Liver cell therapy and tissue engineering for transplantation
Vacanti, J. P., & Kulig, K. M. (2014) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2014.05.001 · Cited by 44
Dai, Y., Guo, Y., Wang, C., Liu, Q., Yang, Y., Li, S. N., Guo, X., Lian, R., Yu, R., Liu, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109856 · Cited by 43
Khazaei, M., Siddiqui, A. M., & Fehlings, M. G. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm4010037 · Cited by 43
Khatib, M. M. E., Ohmine, S., Jacobus, E. J., Tonne, J. M., Morsy, S. G., Holditch, S. J., Schreiber, C. A., Uetsuka, K., Fusaki, N., Wigle, D. A., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0017 · Cited by 43
Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy.
Wei, Z. Z., Zhu, Y., Zhang, J. Y., McCrary, M. R., Wang, S., Zhang, Y., Yu, S., & Wei, L. (2017) · PubMed Central · doi:10.4103/0366-6999.215324 · Cited by 43
Du, Z., Wen, X., Wang, Y., Jia, L., Zhang, S., Liu, Y., Zhou, L., Li, H. Z., Wang, Y., Wang, C., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02444-6 · Cited by 43
Self-citationThe global intellectual property landscape of induced pluripotent stem cell technologies
Roberts, M., Wall, I. B., Bingham, I., Icely, D., Reeve, B. C., Bure, K., French, A., & Brindley, D. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.2975 · Cited by 43
Cellular reprogramming for understanding and treating human disease
Kanherkar, R. R., Bhatia‐Dey, N., Makarev, E., & Csoka, A. B. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00067 · Cited by 43
Current status of treating neurodegenerative disease with induced pluripotent stem cells
Pen, A. E., & Jensen, U. B. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12545 · Cited by 43
Quan, Y., Wei, W., Ergin, V., Rameshbabu, A. P., Huang, M., Tian, C., Saladi, S. V., Indzhykulian, A. A., & Chen, Z. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215253120 · Cited by 42
Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling
Beghini, D. G., Kasai-Brunswick, T. H., & Henriques‐Pons, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042392 · Cited by 42
Stem cell-based organ replacements—Airway and lung tissue engineering
Fishman, J. M., Lowdell, M. W., & Birchall, M. (2014) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2014.04.002 · Cited by 42
Applications of 3D Bioprinted-Induced Pluripotent Stem Cells in Healthcare
Soman, S. S., & Vijayavenkataraman, S. (2024) · International Journal of Bioprinting · doi:10.18063/ijb.v6i4.280 · Cited by 42
Reprogramming neurons for regeneration: The fountain of youth
Yang, S., Wang, X., Qian, C., & Zhou, F. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102284 · Cited by 42
Ayoubi, S., Sheikh, S. P., & Eskildsen, T. V. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx125 · Cited by 42
Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies
Pazzin, D. B., Previato, T. T. R., Gonçalves, J. I. B., Zanirati, G., Xavier, F. A. C., DaCosta, J. C., & Marinowic, D. R. (2024) · Cells · doi:10.3390/cells13090745 · Cited by 41
The function and regulation of mesenchymal-to-epithelial transition in somatic cell reprogramming
Shu, X., & Pei, D. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.08.005 · Cited by 41
Chemically induced pluripotent stem cells (CiPSCs): a transgene-free approach
Masuda, S., Wu, J., Hishida, T., Pandian, G. N., Sugiyama, H., & Belmonte, J. C. I. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt034 · Cited by 41
Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
Chang, C.-Y., Ting, H.-C., Su, H., & Jeng, J. (2018) · Cell Transplantation · doi:10.1177/0963689718754560 · Cited by 41
Replacing reprogramming factors with antibodies selected from combinatorial antibody libraries
Blanchard, J., Xie, J., El-Mecharrafie, N., Gross, S., Lee, S., Lerner, R. A., & Baldwin, K. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3963 · Cited by 41
Zhang, M., Wang, L., An, K., Cai, J., Li, G., Yang, C., Liu, H., Du, F., Han, X., Zhang, Z., et al. (2018) · Cancer Communications · doi:10.1186/s40880-018-0313-0 · Cited by 38
Biomaterial-induced conversion of quiescent cardiomyocytes into pacemaker cells in rats
Hu, Y., Lee, A., Chang, S., Lin, S., Weng, C.-H., Lo, H., Chou, P.-C., Tsai, Y.-N., Sung, Y., Chen, C., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00812-y · Cited by 41
Induced Pluripotent Stem Cells and Their Applications in Amyotrophic Lateral Sclerosis
Du, H., Huo, Z., Chen, Y., Zhao, Z., Meng, F., Wang, X., Liu, S., Zhang, H., Zhou, F., Liu, J., et al. (2023) · Cells · doi:10.3390/cells12060971 · Cited by 41
Reprogramming antitumor immunity
Crompton, J. G., Clever, D. C., Vizcardo, R., Rao, M. S., & Restifo, N. P. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.003 · Cited by 41
Liu, Y., Li, P., Liu, K., He, Q., Han, S., Sun, X., Li, T., & Shen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109588 · Cited by 41
Self-citationCantz, T., Sharma, A. D., & Ott, M. (2015) · Stem Cells · doi:10.1002/stem.1920 · Cited by 40
Understanding the roadmaps to induced pluripotency
Liu, K., Song, Y., Yu, H., & Zhao, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.205 · Cited by 40
Self-citationHan, L. K., Pandian, G. N., Chandran, A., Sato, S., Taniguchi, J., Kashiwazaki, G., Sawatani, Y., Hashiya, K., Bando, T., Xu, Y. F., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503607 · Cited by 40
Generation of human induced pluripotent stem cells using non-synthetic mRNA
Rohani, L., Fabian, C., Holland, H., Naaldijk, Y., Dressel, R., Löffler-Wirth, H., Binder, H., Arnold, A., & Stolzing, A. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.03.008 · Cited by 35
Metabolism Is a Key Regulator of Induced Pluripotent Stem Cell Reprogramming
Spyrou, J., Gardner, D. K., & Harvey, A. J. (2019) · Stem Cells International · doi:10.1155/2019/7360121 · Cited by 40
Afra, S., & Matin, M. M. (2020) · Cell and Tissue Research · doi:10.1007/s00441-019-03161-0 · Cited by 41
Fishman, J. M., Wiles, K., & Wood, K. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800196-7.00008-6 · Cited by 40
Neural crest cells: From developmental biology to clinical interventions
Noisa, P., & Raivio, T. (2014) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21074 · Cited by 40
Recellularization of organs: what is the future for solid organ transplantation?
Moser, P. T., & Ott, H. C. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000131 · Cited by 40
Kang, P. J., Moon, J.-H., Yoon, B. S., Hyeon, S., Jun, E. K., Park, G., Yun, W., Park, J., Park, M., Kim, A., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.015 · Cited by 40
Induced pluripotent stem cells: origins, applications, and future perspectives
Zhao, J. Y., Jiang, W., Sun, C., Hou, C., Yang, X., & Gao, J. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300215 · Cited by 40
Metabolic control of cancer cell stemness: Lessons from iPS cells
Menéndez, J. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1022697 · Cited by 40
The NuRD complex cooperates with SALL4 to orchestrate reprogramming
Wang, B., Li, C., Ming, J., Wu, L., Fang, S., Huang, Y., Lin, L., Liu, H., Kuang, J., Zhao, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38543-0 · Cited by 39
“…achieved through non-Yamanaka methods such as combinations of factors or chemicals suggests that reprogramming can start at divergent points or pathways 11 – 16 , but eventually converge to a common path towards pluripotency, thus, unifying the classic Yamanaka system with all these alternatives.”
Self-citationAdvancing Small‐Molecule‐Based Chemical Biology with Next‐Generation Sequencing Technologies
Chandran, A., Kizaki, S., Bando, T., Pandian, G. N., & Sugiyama, H. (2014) · ChemBioChem · doi:10.1002/cbic.201402556 · Cited by 39
Stemistry: The Control of Stem Cells in Situ Using Chemistry
Davies, S. G., Kennewell, P. D., Russell, A. J., Seden, P. T., Westwood, R., & Wynne, G. M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm500838d · Cited by 40
Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
Tousley, A. R., & Kegel-Gleason, K. B. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160199 · Cited by 39
Efficient Generation of Chemically Induced Mesenchymal Stem Cells from Human Dermal Fibroblasts
Lai, P., Lin, H., Chen, S., Yang, S., Hung, K.-H., Chang, C.-F., Chang, H., Lu, F. L., Lee, Y., Liu, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep44534 · Cited by 39
Stem cells and heart disease - Brake or accelerator?
Steinhoff, G., Nesteruk, J., Wolfien, M., Große, J., Ruch, U., Vasudevan, P., & Müller, P. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.007 · Cited by 39
Sweat gland regeneration: Current strategies and future opportunities
Chen, R., Zhu, Z., Ji, S., Geng, Z., Hou, Q., Sun, X., & Fu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120201 · Cited by 39
Kim, H., Song, B., Park, S., Choi, S. W., Moon, H., Hwang, K., Kang, S., Moon, S., Yang, Y., Kwon, I. C., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj6621 · Cited by 39
Potential application of cell reprogramming techniques for cancer research
Saito, S., Lin, Y., Nakamura, Y., Eckner, R., Wuputra, K., Kuo, K., Lin, C., & Yokoyama, K. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2924-7 · Cited by 39
Stem cell bioprocess engineering towards cGMP production and clinical applications
Sart, S., Schneider, Y., Li, Y., & Agathos, S. N. (2014) · Cytotechnology · doi:10.1007/s10616-013-9687-7 · Cited by 38
Self-citationHuman induced pluripotent stem cells for monogenic disease modelling and therapy
Spitalieri, P., Talarico, V. R., Murdocca, M., Novelli, G., & Sangiuolo, F. C. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i4.118 · Cited by 38
Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson’s Disease
Chen, W., Huang, Q., Ma, S., & Li, M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00389 · Cited by 38
Liu, G., Zhou, Y., Zhang, X., & Guo, S. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01044e · Cited by 38
Self-citationNoncoding RNAs in the Regulation of Pluripotency and Reprogramming
Sherstyuk, V. V., Medvedev, S. P., & Zakian, S. M. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9782-9 · Cited by 38
Biological importance of OCT transcription factors in reprogramming and development
Kim, K.-P., Han, D. W., Kim, J., & Schöler, H. R. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00637-4 · Cited by 37
Quantum-enhanced diamond molecular tension microscopy for quantifying cellular forces
Xu, F., Zhang, S., Ma, L., Hou, Y. X., Li, J., Denisenko, A., Li, Z., Spatz, J. P., Wrachtrup, J., Lei, H., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi5300 · Cited by 37
Human induced pluripotent stem cells: A disruptive innovation
Vos, J. D., Bouckenheimer, J., Sansac, C., Lemaître, J.-M., & Assou, S. (2016) · Current Research in Translational Medicine · doi:10.1016/j.retram.2016.04.001 · Cited by 37
An overview of mammalian pluripotency
Wu, J., Yamauchi, T., & Belmonte, J. C. I. (2016) · Development · doi:10.1242/dev.132928 · Cited by 37
Applied Induced Pluripotent Stem Cells in Combination With Biomaterials in Bone Tissue Engineering
Ardeshirylajimi, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25996 · Cited by 37
CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
Chaterji, S., Ahn, E. H., & Kim, D.-H. (2017) · Theranostics · doi:10.7150/thno.18456 · Cited by 35
Wang, J., Zhou, J., Zhang, N., Zhang, X., & Li, Q. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.016 · Cited by 37
Self-citationMetabolic restructuring and cell fate conversion
Prigione, A., Ruiz-Pérez, M. V., Bukowiecki, R., & Adjaye, J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1834-1 · Cited by 38
Ursu, A., Illich, D. J., Takemoto, Y., Porfetye, A. T., Zhang, M., Brockmeyer, A., Janning, P., Watanabe, N., Osada, H., Vetter, I. R., et al. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.02.015 · Cited by 37
Sułkowski, M., Konieczny, P. S., Chlebanowska, P., & Majka, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010197 · Cited by 37
Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases
Zhang, X., Hu, D., Shang, Y., & Qi, X. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.03.004 · Cited by 38
Self-citationQin, J., Zhang, J., Jiang, J., Zhang, B., Li, J., Lin, X., Wang, S., Zhu, M., Fan, Z., Lv, Y., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.07.004 · Cited by 36
Self-citationClayton, Z. E., Sadeghipour, S., & Patel, S. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.038 · Cited by 36
Novel chemical attempts at ex vivo hematopoietic stem cell expansion
Zhang, Y., & Gao, Y. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-1962-x · Cited by 36
Age reprogramming and epigenetic rejuvenation
Singh, P. B., & Newman, A. G. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0244-7 · Cited by 36
Hu, Y., Zhang, F., Zhong, W., Liu, Y., He, Q., Yang, M., Chen, H., Xu, X., Bian, K., Xu, J., et al. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01929d · Cited by 36
Self-citationPan, S., Zhao, N., Feng, X., Jie, Y., & Jin, Z. (2021) · Science Advances · doi:10.1126/sciadv.abg5749 · Cited by 37
Smith, D. K., He, M., Zhang, C., & Zheng, J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.006 · Cited by 36
Shi, Z., Zhang, J., Chen, S., Li, Y., Lei, X., Qiao, H., Zhu, Q., Hu, B., Zhou, Q., & Jiao, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.709808 · Cited by 36
Self-citationEpigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications
Qin, H., Zhao, A., Zhang, C., & Fu, X. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9682-4 · Cited by 36
Wang, L., Chen, Y., Guan, C., Zhao, Z., Li, Q., Yang, J., Mo, J., Wang, B., Wu, W., Yang, X., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0698-8 · Cited by 36
Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
“Chemical programming is an attractive “zero-footprint” reprogramming method for clinical-grade iPSC generation [42–44]; however, most of the chemical reprogramming methods developed so far have used mouse cells because of their stable epigenome and high plasticity compared to human cells [45–48].”
BackgroundThyroid Cell Differentiation from Murine Induced Pluripotent Stem Cells
Ma, R., MORSHED, S. A., Latif, R., & Davies, T. F. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00056 · Cited by 35
FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells
Yu, F., Wei, R., Yang, J., Liu, J., Yang, K., Wang, H., Mu, Y., & Hong, T. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.022 · Cited by 35
Generation of Stable Induced Pluripotent Stem-like Cells from Adult Zebra Fish Fibroblasts
Peng, L., Zhou, Y., Xu, W., Jiang, M., Li, H., Long, M., Liu, W., Liu, J., Zhao, X., & Xiao, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.34010 · Cited by 35
Self-citationDirect chemical induction of hepatocyte‐like cells with capacity for liver repopulation
Bai, Y., Yang, Z., Xu, X., Ding, W., Qi, J., Liu, F., Wang, X., Zhou, B., Zhang, W., Zhuang, X., et al. (2023) · Hepatology · doi:10.1002/hep.32686 · Cited by 35
Self-citationInterplay of phytohormones and epigenetic regulation: A recipe for plant development and plasticity
Jiang, K., Guo, H., & Zhai, J. (2022) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13384 · Cited by 35
Conversion of mouse fibroblasts into cardiomyocyte-like cells using small molecule treatments
Park, G., Yoon, B. S., Kim, Y. S., Choi, S., Moon, J.-H., Kwon, S., Hwang, J., Yun, W., Kim, J.-H., Park, C., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.029 · Cited by 35
Chen, X. X., Zhai, Y., Yu, D., Cui, J., Hu, J., & Li, W. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25270 · Cited by 35
Biophysical regulation of cell reprogramming
Wong, S. Y., Soto, J., & Li, S. (2017) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2017.01.001 · Cited by 36
Li, X., Xia, C., Wang, T., Liu, L., Zhao, Q., Yang, D., Hu, F., Zhang, M., Huang, K., Geng, Y., et al. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.03.014 · Cited by 35
In vivo reprogramming for tissue regeneration and organismal rejuvenation
Taguchi, J., & Yamada, Y. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.008 · Cited by 35
The fate of cell reprogramming
Karagiannis, P., & Yamanaka, S. (2014) · Nature Methods · doi:10.1038/nmeth.3109 · Cited by 34
Pereira, S. M., Ribeiro, R., & Logarinho, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040938 · Cited by 34
Induced Pluripotent Stem Cell Technology: Trends in Molecular Biology, from Genetics to Epigenetics
Maali, A., Maroufi, F., Sadeghi, F., Atashi, A., Kouchaki, R., Moghadami, M., & Azad, M. (2021) · Epigenomics · doi:10.2217/epi-2020-0409 · Cited by 34
Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane
Heller, J. P., & Martin, K. R. G. (2014) · Translational Vision Science & Technology · doi:10.1167/tvst.3.4.4 · Cited by 34
Liu, H., Su, S., Ma, S., Li, T., Wang, F., Ding, Y., Liu, S., Zhang, J., Xiang, H., Zhou, X., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c02615 · Cited by 34
Wang, C., Zhu, K., Li, J., Lai, H., Wang, C., & Lai, H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73961 · Cited by 34
Golchin, A., Rekabgardan, M., Taheri, R. A., & Nourani, M. R. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_256 · Cited by 34
Metadata
- Authors
- Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., & Deng, H.
- Affiliations
- Peking University (CN)
- Beijing Vitalstar Biotechnology Co., Ltd., Beijing 100012, China.
- Corresponding author
- Hou, Pingping
- Li, Yanqin
- Zhang, Xu
- Liu, Chun
- Guan, Jingyang
- Li, Honggang
- Zhao, Ting
- Ye, Junqing
- Yang, Weifeng
- Liu, Kang
- Ge, Jian
- Xu, Jun
- Zhang, Qiang
- Zhao, Yang
- Deng, Hongkui
- ORCID
- Venue
- Science
- Published
- 2013-08-09
- Volume
- 341
- Issue
- 6146
- Pages
- 651-654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101569447
- Cited by
- 1,402
- References
- 38
- Citations by year
- 2026: 51 · 2025: 76 · 2024: 78 · 2023: 77 · 2022: 72 · 2021: 85 · 2020: 84 · 2019: 84 · 2018: 114 · 2017: 114 · 2016: 161 · 2015: 165 · 2014: 182 · 2013: 59
- FWCI
- 84.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Microsoft Research
- York University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- pluripotent stem cells, chemical reprogramming, small molecules, somatic cell reprogramming, induced pluripotent stem cells, germline transmission, epigenetic status, differentiation potential, master genes
- MeSH terms
- Animals, Fibroblasts, Mice, Inbred C57BL, Mice, Inbred ICR, Promoter Regions, Genetic, Cadherins, Gene Expression Profiling, Green Fluorescent Proteins, Octamer Transcription Factor-3, Mice, Small Molecule Libraries, Induced Pluripotent Stem Cells, Epithelial-Mesenchymal Transition, Cell Engineering, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.